Recent research supports our finding that ST3GAL1 expression is increased in serous ovarian cancer and demonstrates that ST3GAL1 may regulate ovarian cancer cell migration and peritoneal dissemination via epidermal growth factor receptor (EGFR) signaling37. This evidence concerns the gene EGFR and ovarian serous adenocarcinoma.